Treatment efficacy of trimethoprim sulfamethoxazole, pentoxifylline and altrenogest in experimentally induced equine placentitis

Theriogenology

Volumn 74, Issue 3, 2010, Pages 402-412

  Bailey, C S ^a,c   Macpherson, M L ^a   Pozor, M A ^a   Troedsson, M H T ^a,d   Benson, S ^a   Giguere, S ^a,e   Sanchez, L C ^a   LeBlanc, M M ^b   Vickroy, T W ^a  

^a University of Florida   (United States)

^b ROOD AND RIDDLE EQUINE HOSPITAL   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRENOGEST; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; COTRIMOXAZOLE; DRUG DERIVATIVE; PENTOXIFYLLINE; PROGESTERONE DERIVATIVE; TRENBOLONE; TRENBOLONE ACETATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DRUG COMBINATION; FEMALE; FETUS; HORSE; HORSE DISEASE; MICROBIOLOGY; PATHOLOGY; PLACENTA DISORDER; PREGNANCY; PREGNANCY OUTCOME; ANALOGS AND DERIVATIVES; HORSE DISEASES; PLACENTA DISEASES; VETERINARY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FETUS; HORSE DISEASES; HORSES; PENTOXIFYLLINE; PLACENTA DISEASES; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE CONGENERS; TRENBOLONE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TRENBOLONE ACETATE;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUI SUBSP. ZOOEPIDEMICUS;

EID: 77954535514     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2010.02.023     Document Type: Article

References (62)

1. Giles R.C., Donahue J.M., Hong C.B., Tuttle P.A., Petritesmurphy M.B., Poonacha K.B., et al. Causes of abortion, stillbirth, and perinatal death in horses - 3,527 cases (1986-1991). J Am Vet Med Assoc 1993, 203:1170-1175.
2. Hong C.B., Donahue J.M., Giles R.C., Petritesmurphy M.B., Poonacha K.B., Roberts A.W., et al. Etiology and pathology of equine placentitis. J Vet Diag Investigation 1993, 5:56-63.
3. Platt H. Infection of the horse fetus. J Reprod Fert Suppl 1975, 23:605-610.
4. Smith K.C., Blunden A.S., Whitwell K.E., Dunn K.A., Wales A.D. A survey of equine abortion, stillbirth and neonatal death in the UK from 1988 to 1997. Eq Vet J 2003, 35:496-501.
5. Whitwell K. Equine Infectious Diseases V 1988, University of Kentucky Press, Lexington. 5th ed.
6. Mays M.B.C., Leblanc M.M., Paccamonti D. Route of fetal infection in a model of ascending placentitis. Theriogenology 2002, 58:791-792.
7. Smith K.C., Blunden A.S., Whitwell K.E., Dunn K.A., Wales A.D. A survey of equine abortion, stillbirth and neonatal death in the UK from 1988 to 1997. Eq Vet J 2003, 35:496-501.
8. Rossdale P.D., Ousey J.C., Cottrill C.M., Chavatte P., Allen W.R., McGladdery A.J. Effects of placental pathology on maternal plasma progestagen and mammary secretion calcium concentrations and on neonatal adrenocortical function in the horse. J Reprod Fertil 1991, 579-590.
9. Sertich P.L., Vaala W.E. Concentrations of antibiotics in mares, foals and fetal fluids after antibiotic administration in late pregnancy. Proc Am Assoc Equine Pract 1992, 38:727-736.
10. Santschi E.M., Papich M.G. Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation. J Vet Pharmacol Ther 2000, 23:359-363.
11. Murchie T.A., Macpherson M.L., Leblanc M.M., Luznar S., Vickroy T.W. Continuous monitoring of penicillin G and gentamicin in allantoic fluid of pregnant pony mares by in vivo microdialysis. Eq Vet J 2006, 38:520-525.
12. Rebello S.A., Macpherson M.L., Murchie T.A., Leblanc M.M., Vickroy T.W. Placental transfer of trimethoprim sulfamethoxazole and pentoxifylline in pony mares. Anim Reprod Sci 2006, 94:432-433.
13. Jacks S.S., Giguere S., Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials. Antimicrob Agents Chemother 2003, 47:1742-1745.
14. Graczyk J., Macpherson M.L., Pozor M.A., Troedsson M.H.T., Eichelberger A.C., Leblanc M.M., et al. Treatment efficacy of trimethoprim sulfamethoxazole and pentoxifylline in equine placentitis. Anim Reprod Sci 2006, 94:434-435.
15. Troedsson M.H.T., Zent W.W. Clinical ultrasonographic evaluation of the equine placenta as a method to successfully identify and treat mares with placentitis. Proc Workshop on the Equine Placenta 2004, UK Agricultural Experimental Station 1, 66-67.
16. Gravett M.G., Adams K.M., Sadowsky D.W., Grosvenor A.R., Witkin S.S., Axthelm M.K., et al. Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007, 197:518.
17. Gravett M., Sadowsky D., Witkin S., Novy M. Immunomodulators plus antibiotics to prevent preterm delivery in experimental intra-amniotic infection (IAI). Am J Obstet Gynecol 2003, 189:S56.
18. Renaudin C.D., Troedsson M.H.T., Gillis C.L., King V.L., Bodena A. Ultrasonographic evaluation of the equine placenta by transrectal and transabdominal approach in the normal pregnant mare. Theriogenology 1997, 47:559-573.
19. Renaudin C.D., Liu I.K.M., Troedsson M.H.T., Schrenzel M.D. Transrectal ultrasonographic diagnosis of ascending placentitis in the mare: a report of two cases. Eq Vet Ed 1999, 11:69-74.
20. Troedsson M.H.T., Renaudin C.D., Zent W.W., Steiner J.V. Transrectal ultrasonography of the placenta in normal mares and mares with pending abortion: a field study. Proc Am Assoc Eq Prac 1997, 43:256-258.
21. Renaudin C.D., Troedsson M.H.T., Gillis C.L. Transrectal ultrasonographic evaluation of the normal equine placenta. Eq Vet Ed 1999, 11:75-76.
22. Reef V.B., Vaala W.E., Worth L.T., Spencer P.A., Hammett B. Ultrasonographic evaluation of the fetus and intrauterine environment in healthy mares during late-gestation. Vet Radiol Ultrasound 1995, 36:533-541.
23. Reef V.B., Vaala W.E., Worth L.T., Sertich P.L., Spencer P.A. Ultrasonographic assessment of fetal well-being during late gestation: Development of an equine biophysical profile. Eq Vet J 1996, 28:200-208.
24. Murchie T.A., Macpherson M.L., Leblanc M.M., Luznar S.L., Vickroy T.W. A microdialysis model to detect drugs in the allantoic fluid of pregnant pony mares. Am Assoc Eq Pract 2003, 49:118-119.
25. Stawicki R. Establishment for a model of ascending placentitis in the pony mare: endocrinology, microbiology and clinical findings. Thesis/Dissertation 2001, University of Florida.
26. Stawicki R.J., Ruebel H., Hansen P.J., Sheerin B.R., O'Donnell L.J., Lester G.D., et al. Endocrinological findings in an experimental model of ascending placentitis in the mare. Theriogenology 2002, 58:849-852.
27. Koterba A.M. Prematurity, section one: identification, Assessment and Treatment. Equine Clinical Neonatology 1990, 55-65. Lea & Febiger Ltd. A.M. Koterba, W.H. Drummond, P.C. Kosch (Eds.).
28. Silver M., Ousey J.C., Dudan F.E., Fowden A.L., Knox J., Cash R.S.G., et al. Studies on equine prematurity. 2. Post natal adrenocortical activity in relation to plasma adrenocorticotropic hormone and catecholamine levels in term and premature foals. Eq Vet J 1984, 16:278-286.
29. Ousey J.C., Rossdale P.D., Fowden A.L., Palmer L., Turnbull C., Allen W.R. Effects of manipulating intrauterine growth on post natal adrenocortical development and other parameters of maturity in neonatal foals. Eq Vet J 2004, 36:616-621.
30. Jeffcott L.B. Passive-immunity and its transfer with special reference to horse. Biol Rev Camb Philos Soc 1972, 47:439-464.
31. Jeffcott L.B. Studies on passive-immunity in foal. 1. Gamma-globulin and antibody variations associated with maternal transfer of immunity and onset of active immunity. J Comp Path 1974, 84:93-101.
32. Chavatte P., Clement F., Cash R., Gronget J.-F. Field determination of colostrum quality by using a novel, practical method. Am Assoc Eq Pract 1998, 44:206-209.
33. Wong D.M., Vo D.T., Alcott C.J., Stewart A.J., Peterson A.D., Sponseller B.A., et al. Adrenocorticotropic hormone stimulation tests in healthy foals from birth to 12 weeks of age. Can J Vet Res 2009, 73:65-72.
34. Wong D.M., Vo D.T., Alcott C.J., Peterson A.D., Sponseller B.A., Hsu W.H. Baseline plasma cortisol and ACTH concentrations and response to low-dose ACTH stimulation testing in ill foals. J Am Vet Med Assoc 2009, 234:126-132.
35. Romero R., Mazor M., Wu Y.K., Sirtori M., Oyarzun E., Mitchell M.D., et al. Infection in the pathogenesis of preterm labor. Sem Perinatol 1988, 12:262-279.
36. Romero R., Mazor M. Infection and pretermlabor. Clin Obstet Gynec 1988, 31:553-584.
37. Goncalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Mental Retard Devel Disabil Res Rev 2002, 8:3-13.
38. Guinn D.A., Goldenberg R.L., Hauth J.C., Andrews W.W., Thom E., Romero R. Risk-factors for the development ofpreterm premature rupture of the membranes after arrest of preterm labor. Am J Obstet Gynec 1995, 173:1310-1315.
39. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001, 357:979-988.
40. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001, 357:989-994.
41. Zent W.W., Williams N.M., Donahue J.M. Placentitis in central Kentucky broodmares. Pferdeheilkunde 1999, 15:630-632.
42. Ensink J.M., Vanklingeren B., Houwers D.J., Klein W.R., Vulto A.G. In-vitro susceptibility to antimicrobial drugs of bacteriaisolates from horses in the Netherlands. Eq Vet J 1993, 25:309-313.
43. Lauterbach R., Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Europ J Pediatrics 1996, 155:404-409.
44. Baskett A., Barton M.H., Norton N., Anders B., Moore J.N. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am J Vet Res 1997, 58:1291-1299.
45. McGlothlin J.A., Lester G.D., Hansen P.J., Thomas M., Pablo L., Hawkins D.L., et al. Alteration in uterine contractility in mares with experimentally induced placentitis. Reproduction 2004, 127:57-66.
46. Lye S.J., Porter D.G. Demonstration that progesterone blocks uterine activity in ewe in vivo by a direct action on myometrium. J Reprod Fertil 1978, 52:87-94.
47. Kubli-Garfias C., Medrano-Conde L., Beyer C., Bondani A. In vitro inhibition of rat uterine contractility induced by 5 alpha and 5 beta progestins. Steroids 1979, 34:609-617.
48. Csapo A.I., Takeda H. Effect of progesterone on electric activity and intrauterine pressure of pregnant and parturient rabbits. Am J Obstet Gynec 1965, 91:221.
49. Garfield R.E., Rabideau S., Challis J.R.G., Daniel E.E. Hormonal-control of gap junction formation in sheep myometrium during parturition. Biol Reprod 1979, 21:999-1007.
50. Garfield R.E., Kannan M.S., Daniel M.E. Gap junction formation in the myometrium: control by estrogens, progesterone and prostaglandins. Am J Physiol 1980, 238:C81-C89.
51. Bishop C.V., Stormshak F. Nongenomic action of progesterone inhibits oxytocin-induced phosphoinositide hydrolysis and prostaglandin F-2 alpha secretion in the ovine endometrium. Endocrinol 2006, 147:937-942.
52. Schwartz N., Xue X., Elovitz M.A., Dowling O., Metz C.N. Progesterone suppresses the fetal inflammatory response ex vivo. Am J Obstet Gynec 2009, 201:211.
53. Dodd J.M., Flenady V.J., Cincotta R., Crowther C.A. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 2008, 112:127-134.
54. Dodd J.M., Flenady V., Cincotta R., Crowther C.A. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 2006, CD004947.
55. Dodd J.M., Crowther C.A., Cincotta R., Flenady V., Robinson J.S. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005, 84:526-533.
56. Use of progesterone to reduce preterm birth. Obstet Gynec 2008, 112:963-965.
57. Ensink J.M., Bosch G., van Duijkeren E. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp zooepidemicus infection model in ponies. J Vet Pharmacol Ther 2003, 28:45-49.
58. Peyrou M., Higgins R., Lavoie J.P. Evolution of bacterial resistance to certain antibacterial agents in horses in a veterinary hospital. Can Vet J 2003, 44:978-981.
59. Park H.K., Shim S.S., Kim S.Y., Park J.H., Park S.E., Kim H.J., et al. Molecular analysis of colonized bacteria in a human newborn infant gut. J Microbiol 2005, 43:345-353.
60. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999, 27:887-892.
61. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 1999, 103:e39. art.
62. Sanchez L.C., Giguere S., Lester G.D. Factors associated with survival of neonatal foals with bacteremia and racing performance of surviving Thoroughbreds: 423 cases (1982-2007). J Am Vet Med Assoc 2008, 233:1446-1452.